111 related articles for article (PubMed ID: 19721028)
1. Inadequacies of statutory drug compendia also affect the mental health field.
Paczynski RP; Kruszewski SP
Ann Intern Med; 2009 Sep; 151(5):364-5. PubMed ID: 19721028
[No Abstract] [Full Text] [Related]
2. Systematic review: reliability of compendia methods for off-label oncology indications.
Abernethy AP; Raman G; Balk EM; Hammond JM; Orlando LA; Wheeler JL; Lau J; McCrory DC
Ann Intern Med; 2009 Mar; 150(5):336-43. PubMed ID: 19221366
[TBL] [Abstract][Full Text] [Related]
3. Off-label cancer drug compendia found outdated and incomplete.
Mitka M
JAMA; 2009 Apr; 301(16):1645-6. PubMed ID: 19383947
[No Abstract] [Full Text] [Related]
4. Evaluating off-label uses of anticancer drugs: time for a change.
Sox HC
Ann Intern Med; 2009 Mar; 150(5):353-4. PubMed ID: 19221369
[No Abstract] [Full Text] [Related]
5. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
Burkhart CG
J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
[No Abstract] [Full Text] [Related]
6. Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications.
Paczynski RP; Alexander GC; Chinchilli VM; Kruszewski SP
Int J Risk Saf Med; 2012 Jan; 24(3):137-46. PubMed ID: 22936056
[TBL] [Abstract][Full Text] [Related]
7. Compendia and anticancer therapy under Medicare.
Tillman K; Burton B; Jacques LB; Phurrough SE
Ann Intern Med; 2009 Mar; 150(5):348-50. PubMed ID: 19221368
[TBL] [Abstract][Full Text] [Related]
8. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs.
Chao SD; Maibach HI
Am J Clin Dermatol; 2005; 6(2):105-11. PubMed ID: 15799682
[TBL] [Abstract][Full Text] [Related]
9. Caveat emptor: Erroneous safety information about opioids in online drug-information compendia.
Talwar SR; Randhawa AS; Dankiewicz EH; Crudele NT; Haddox JD
J Opioid Manag; 2016; 12(4):281-8. PubMed ID: 27575829
[TBL] [Abstract][Full Text] [Related]
10. Cough.
Stud Anc Med; 2009; 38():225-82. PubMed ID: 20481150
[No Abstract] [Full Text] [Related]
11. Diabetes.
Stud Anc Med; 2009; 38():283-323. PubMed ID: 20481151
[No Abstract] [Full Text] [Related]
12. Comparative assessment of four drug interaction compendia.
Vitry AI
Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
[TBL] [Abstract][Full Text] [Related]
13. Method of the study.
Stud Anc Med; 2009; 38():85-126. PubMed ID: 20481148
[No Abstract] [Full Text] [Related]
14. Controlling off-label medication use.
Gillick MR
Ann Intern Med; 2009 Mar; 150(5):344-7. PubMed ID: 19221367
[TBL] [Abstract][Full Text] [Related]
15. Medieval pharmacotherapy continuity and change. Case studies from Ibn Sinā and some of his late Medieval commentators. Conclusions.
Stud Anc Med; 2009; 38():325-762. PubMed ID: 20481152
[No Abstract] [Full Text] [Related]
16. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.
Olvey EL; Clauschee S; Malone DC
Clin Pharmacol Ther; 2010 Jan; 87(1):48-51. PubMed ID: 19890252
[TBL] [Abstract][Full Text] [Related]
17. While shopping for an herbal supplement, I noticed that some labels say the supplement is USP verified. What does that mean?
Mayo Clin Health Lett; 2004 Oct; 22(10):8. PubMed ID: 15609437
[No Abstract] [Full Text] [Related]
18. Inactive ingredients in medicines.
Wilson JV
Lancet; 1988 Aug; 2(8607):399. PubMed ID: 2899806
[No Abstract] [Full Text] [Related]
19. PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing?
Allen LV
Int J Pharm Compd; 2016; 20(4):268. PubMed ID: 28333670
[No Abstract] [Full Text] [Related]
20. Evolution of a children's drug table.
Shirkey HC
Hosp Formul; 1979 Mar; 14(3):319-20, 325-6, 330. PubMed ID: 10316796
[No Abstract] [Full Text] [Related]
[Next] [New Search]